{"id":"W3028345760","doi":"10.1016/j.jval.2020.04.136","title":"PCV31 COST-EFFECTIVENESS OF EVOLOCUMAB FOR THE TREATMENT OF PATIENTS WITH HYPERCHOLESTEROLEMIA IN THE KINGDOM OF SAUDI ARABIA","year":2020,"lang":"en","type":"article","venue":"Value in Health","topic":"Pharmaceutical Economics and Policy","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"ca_institutions":"Amgen (Canada)","funders":"","keywords":"Evolocumab; Medicine; Familial hypercholesterolemia; Ezetimibe; PCSK9; Statin; Internal medicine; Population; Atherosclerotic cardiovascular disease; Cohort; Observational study; Gastroenterology; Cholesterol; Lipoprotein; Disease; LDL receptor","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001198632,0.0002274262,0.0006502471,0.0003937426,0.0001600211,0.0009256904,0.0003108949,0.0005835512,0.002297366],"category_scores_gemma":[0.005461644,0.0001477863,0.001143532,0.0004777072,0.0003031572,0.0005127559,0.000439092,0.0008391285,0.00009642223],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.003166741,"about_ca_system_score_gemma":0.002145865,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.02763224,"about_ca_topic_score_gemma":0.02326725,"domain_scores_codex":[0.9992027,0.0004223329,0.00007908942,0.0000533796,0.00009900812,0.0001435305],"domain_scores_gemma":[0.9976701,0.00101594,0.0005325524,0.00005028354,0.0002533495,0.0004777658],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"simulation_or_modeling","study_design_scores_codex":[0.1370587,0.001736003,0.4662752,0.003973652,0.007453429,0.001891856,0.0006694837,0.05132711,0.002431175,0.005804543,0.009473372,0.3119056],"study_design_scores_gemma":[0.01915079,0.02089584,0.8779175,0.002146453,0.008081516,0.002557064,0.002182486,0.05218738,0.001436337,0.001964331,0.01132797,0.0001523813],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9846485,0.01151895,0.00008630976,0.001966737,0.00005398567,0.00002819725,0.0005206867,0.00000497563,0.001171707],"genre_scores_gemma":[0.9984323,0.001082823,0.00006060164,0.00009504564,0.00002325199,0.000005781886,0.0001826293,8.895564e-7,0.0001166436],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.02763224,"threshold_uncertainty_score":0.05494279,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1748332683849312,"score_gpt":0.3406081854431775,"score_spread":0.1657749170582463,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}